Literature DB >> 15806479

Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs.

David J Schlieben1, Stephen M Korbet, Robert E Kimura, Melvin M Schwartz, Edmund J Lewis.   

Abstract

Despite clinical and experimental data suggesting a direct relationship between antineutrophil cytoplasmic antibodies (ANCAs) and disease activity in patients with microscopic polyangiitis (MPA), the causal relationship between perinuclear ANCAs specific for myeloperoxidase (MPO-ANCA) and disease manifestations has been controversial. We describe the case of a woman with a history of pulmonary-renal syndrome caused by MPA whose disease became clinically and serologically active during pregnancy. Forty-eight hours after delivery, the newborn developed pulmonary hemorrhage and abnormalities in renal function. The newborn's cord blood showed an immunoglobulin G MPO-ANCA level identical to that of the mother's serum, indicating passive transfer of the antibody to the neonate. Our findings represent the first human model supporting the interpretation that MPO-ANCAs were immunopathogenic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806479     DOI: 10.1053/j.ajkd.2005.01.001

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  45 in total

1.  Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.

Authors:  Mazdak A Khalighi; Shihtien Wang; Kammi J Henriksen; Margret Bock; Mahima Keswani; Anthony Chang; Shane M Meehan
Journal:  Pediatr Nephrol       Date:  2015-02-12       Impact factor: 3.714

2.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology.

Authors:  Dana Carina Baiu; Matyas Sandor; Michael Hart
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 4.  Targeted biologic approaches to the treatment of systemic vasculitis.

Authors:  Andreea Coca; Jennifer H Anolik
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 5.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

6.  Sustained monocyte activation in clinical remission of systemic vasculitis.

Authors:  Agneta Wikman; Joachim Lundahl; Stefan H Jacobson
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

Review 7.  Epigenetics and complementary proteins.

Authors:  D Ciavatta; R J Falk
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

8.  A case of ANCA-associated vasculitis presenting de novo in pregnancy, successfully treated with rituximab.

Authors:  A Pefanis; D S Williams; H Skrzypek; A Fung; K Paizis
Journal:  Obstet Med       Date:  2018-07-26

Review 9.  The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.

Authors:  Nina Svetlicky; Oscar-Danilo Ortega-Hernandez; Luc Mouthon; Loic Guillevin; Hans-Jurgen Thiesen; Arie Altman; Martine Szyper Kravitz; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2012-12-11       Impact factor: 8.317

Review 10.  [Wegener's granulomatosis and microscopic polyangiitis].

Authors:  K de Groot; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.